Robert D. Gordon
9Patents
3h-index
12Co-inventors
54Inventor score
Filing activity: Dec 21, 1999 → Aug 4, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8685998B2 | Tacrolimus for improved treatment of transplant patients | Human Necessities | 20 | Active |
| US8664239B2 | Tacrolimus for improved treatment of transplant patients | Human Necessities | 16 | Active |
| US6783953B1 | Vascular endothelial growth factor-X | Chemistry; Metallurgy | 3 | Expired |
| US11110081B2 | Tacrolimus for improved treatment of transplant patients | Human Necessities | 2 | Active |
| US11123331B2 | Tacrolimus for improved treatment of transplant patients | Human Necessities | 1 | Active |
| US10864199B2 | Tacrolimus for improved treatment of transplant patients | Human Necessities | 1 | Active |
| US7179890B2 | Vascular endothelial growth factor-x | Chemistry; Metallurgy | 1 | Expired |
| US7482320B2 | Modulation of smooth muscle cell proliferation | Physics | 0 | Expired |
| US12083103B2 | Tacrolimus for improved treatment of transplant patients | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.